Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Troy Nathaniel Benson, M.D.
Family Practice · WASECA, MN · NPI 1194010041
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 363 | 98 |
| Metoprolol Succinate | Metoprolol Succinate | 331 | 85 |
| Levothyroxine Sodium | Levothyroxine Sodium | 294 | 67 |
| Lisinopril | Lisinopril | 276 | 70 |
| Amlodipine Besylate | Amlodipine Besylate | 273 | 76 |
| Losartan Potassium | Losartan Potassium | 259 | 65 |
| Omeprazole | Omeprazole | 250 | 69 |
| Metformin Hcl Er | Metformin Hcl | 244 | 61 |
| Gabapentin | Gabapentin | 201 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 195 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 182 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 46 |
| Furosemide | Furosemide | 149 | 43 |
| Simvastatin | Simvastatin | 148 | 35 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 145 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 130 | 50 |
| Tramadol Hcl | Tramadol Hcl | 130 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 33 |
| Allopurinol | Allopurinol | 122 | 27 |
| Jardiance | Empagliflozin | 111 | 22 |
| Eliquis | Apixaban | 78 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 21 |
| Oxycodone Hcl | Oxycodone Hcl | 73 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 70 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 66 | 17 |
| Nortriptyline Hcl | Nortriptyline Hcl | 66 | 12 |
| Metformin Hcl | Metformin Hcl | 64 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 64 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 64 | 23 |
| Lorazepam | Lorazepam | 63 | 16 |
| Memantine Hcl | Memantine Hcl | 63 | 13 |
| Warfarin Sodium | Warfarin Sodium | 63 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 61 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 60 | 15 |
| Chlorthalidone | Chlorthalidone | 59 | 13 |
| Famotidine | Famotidine | 59 | 19 |
| Montelukast Sodium | Montelukast Sodium | 58 | 15 |
| Pregabalin | Pregabalin | 58 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 56 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | suppressed |
| Carvedilol | Carvedilol | 55 | 18 |
| Finasteride | Finasteride | 55 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 54 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 53 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | 19 |
| Glimepiride | Glimepiride | 53 | 16 |
| Trulicity | Dulaglutide | 52 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 11 |
| Clonazepam | Clonazepam | 49 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 49 | 17 |
| Trazodone Hcl | Trazodone Hcl | 49 | 18 |
| Prednisone | Prednisone | 47 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Atenolol | Atenolol | 43 | 14 |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 40 | suppressed |
| Glipizide Er | Glipizide | 40 | suppressed |
| Potassium Chloride | Potassium Chloride | 38 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 36 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 36 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 35 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 35 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 32 | suppressed |
| Spironolactone | Spironolactone | 32 | 12 |
| Celecoxib | Celecoxib | 31 | suppressed |
| Ozempic | Semaglutide | 31 | suppressed |
| Bupropion Xl | Bupropion Hcl | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | suppressed |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 24 |
| Mirtazapine | Mirtazapine | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 28 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Jantoven | Warfarin Sodium | 25 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Naproxen | Naproxen | 24 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 24 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 22 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Rybelsus | Semaglutide | 21 | suppressed |
| Torsemide | Torsemide | 21 | 11 |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Nystatin | Nystatin | 17 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Meloxicam | Meloxicam | 16 | suppressed |
| Alprazolam | Alprazolam | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Azithromycin | Azithromycin | 14 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | 11 |
| Klor-Con M10 | Potassium Chloride | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Metoprolol-Hydrochlorothiazide | Metoprolol/Hydrochlorothiazide | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Itraconazole | Itraconazole | 12 | suppressed |
| Peg-3350 And Electrolytes | Peg3350/Sod Sulf,bicarb,cl/Kcl | 12 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error